This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

ORIX Ventures Announces $10 Million Growth Capital Commitment To Talyst

ORIX Ventures announces the closing of a $10 million growth capital commitment to Talyst. The funding is structured to provide immediate growth capital to the company. Initial proceeds will be used to support Talyst’s expansion into the long-term care and correctional markets, as well as its plans to achieve greater penetration in acute-care market.

Located in Seattle, Washington, Talyst is a leader in pharmacy automation providing enterprise-wide medication management across entire health systems. Its solutions offer greater inventory control, enhanced workflow efficiency and improved patient safety. Talyst was founded in 2002 to provide easy-to-use, automated medication management systems to acute-care hospital pharmacies.

The funding of Talyst underscores ORIX Ventures’ intent to forge partnerships with fast-growing, later stage companies, as well as its particular interest in health care companies.

“We believe this funding from ORIX Ventures validates the market leadership and growth potential of Talyst,” said CEO Carla Corkern. “Having a strong partner, such as ORIX Ventures, which can support the financial needs of Talyst throughout our expansion gives us a competitive edge by enabling us to respond quickly to marketplace opportunities.”

David Orlandella, a Principal at ORIX Ventures, commented, “We are pleased to partner with Talyst’s management team which has demonstrated an impressive ability to strategically scale the company and build a leading technology company in the pharmacy automation space.”

About ORIX Ventures

ORIX Ventures provides customized financial solutions up to $50 million in capital per transaction to mid- and late-stage companies which have established customers and run-rate revenues of $10 million or greater. Since its inception in 2001, ORIX Ventures has invested in more than 100 growth companies throughout the U.S. and Canada. www.orixventures.com. ORIX USA is a Dallas, Texas-based financial services and investment firm with more than 1,400 employees and primary offices in Dallas, New York, Los Angeles, Columbus and Minneapolis. ORIX USA holds approximately $6 billion of assets and manages through various subsidiaries an additional $25 billion. www.orix.com. ORIX USA is a wholly owned subsidiary of ORIX Corporation, a Tokyo-based, publicly owned international financial services company with operations in 27 countries worldwide. ORIX Corporation is listed on the Tokyo (8591) and New York Stock Exchanges (IX).

Follow us on Twitter: @orixventures

About Talyst

Talyst is a leader in pharmacy automation and engineers the safer pharmacy. The company’s solutions provide enterprise-wide medication management across entire health systems to offer greater inventory control, enhanced workflow efficiency, and improved patient safety. As of 2012, Talyst has installed automated systems in more than 600 integrated healthcare systems, acute-care hospitals, long-term care facilities, and correctional institutions. Talyst offers a powerful software platform with a suite of hardware components to meet specific needs of health care providers. Visit Talyst at www.talyst.com.



1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,011.94 -28.43 -0.16%
S&P 500 2,109.60 -2.13 -0.10%
NASDAQ 5,076.5240 -6.4050 -0.13%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs